Peer-Reviewed Publications Citing Vectra
Bibliography
VectraDA
2020
Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: Results from Two Randomized, Controlled Phase 2b Trials. (2020) Tarrant JM, Galien R, Li W, Goyal L, Pan Y, Hawtin R, Zhang W, Van der Aa A, Taylor PC Rheumatol Ther
Synovial tissue transcriptomes of long-standing rheumatoid arthritis are dominated by activated macrophages that reflect microbial stimulation (2020) Smilijanovic B, Grutzkau A, Sorensen T, Grun JR, Vogl T, Bonin M, Schendel P, Stuhlmuller B, Claussnitzer A, Hermann S, Ohrndorf S, Aupperle K, Backhaus M, Radbruch A, Burmester GR, Haupl T Scientific Reports
Multiple Biomarker Approach for the Diagnosis and Therapy of Rheumatoid Arthritis (2020) Savvateeva E, Smoldovskaya O, Feyzkhanova G, Rubina A Critical Reviews in Clinical Laboratory Sciences
Back To Top
2019
Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis (2019) Curtis JR, Flake DD 2nd, Weinblatt ME, Shadick NA, Ostergaard M, Hetland ML, Brahe CH, Hwang YG, Furst DE, Strand V, Etzel CJ, Pappas DA, Wang X, Hwang CC, Sasso EH, Gutin A, Hitraya E, Lanchbury JS Rheumatology
Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis. (2019) Lai JH, Luo SF, Ho LJ Cells
Back To Top
2018
Digital Health: a new dimension in rheumatology patient care (2018) Kataria S, Ravindran V Rheumatology International
Proteomics in Chronic Arthritis - Will We Finally Have Useful Biomarkers? (2018) Kessel C, McArdle A, Verweyen E, Weinhage T, Wittkowski H, Pennington SR, Foell D Current Rheumatology Reports
Flares in Rheumatoid Arthritis Patients with Low Disease Activity: Predictability and Association with Worse Clinical Outcomes. (2018) Bechman K, Tweehuysen L, Garrood T, Scott DL, Cope AP, Galloway JB, Ma MHY The Journal of Rheumatology
Determination of the minimally important difference (MID) in multi-biomarker disease activity (MBDA) test scores: impact of diurnal and daily biomarker variation patterns on MBDA scores (2018) Chernoff D, Scott Eastman P, Hwang CC, Flake DD 2nd, Wang X, Kivitz A, Curtis JR Clinical Rheumatology
Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond (2018) Karnell JL, Amcaoglu Rider S, Ettinger R, Kolbeck R Advanced Drug Delivery Reviews
Back To Top
2017
A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis after Methotrexate Failure (2017) Hambardzumyan K, Saevarsdottir S, Forslind K, Petersson IF, Wallman JK, Ernestam S, Bolce RJ, van Vollenhoven RF Arthritis Rheumatol
A Multibiomarker Disease Activity Score for Rheumatoid Arthritis Predicts Radiographic Joint Damage in the BeSt Study (2017) Markusse IM, Dirven L, van den Broek M, Bijkerk C, Han K.H, Ronday H.K, Bolce R, Sasso E, Kerstens P, Lems WF, Huizinga T, and Allaart CF J Rheumatol.
Altered Expression of MicroRNAs in Rheumatoid Arthritis (2017) Tavasolian E, Abdollahi E, Rezaei R, Momtazi AA, Henrotin Y, Sahebkar A J. Cell. Biochem.
Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs. (2017) McArdle A, Pennington S, FitzGerald O Clin Rev Allergy Immunol.
Back To Top
2016
Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice (2016) Hirata S, Li W, Kubo S, Fukuyo S, Mizuno Y, Hanami K, Sawamukai N, Yamaoka K, Saito K, Defranoux NA, Tanaka Y Mod Rheumatol
Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial (2016) Hambardzumyan K, Bolce RJ, Saevarsdottir S, Forslind K, Wallman JK, Cruickshank SE, Sasso E, Chernoff D and Van Vollenhoven R RMD
Biomarkers in Rheumatoid Arthritis, what is new? (2016) Gavrila BI, Ciofu C, and Stoica V J Med Life
Back To Top
2015
Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgia (2015) Lee YC, Hackett J, Frits M, Iannaccone C, Shadick N, Weinblatt M, Segurado O and Sasso E Rheumatology
Enhancement of Patient Recruitment in Rheumatoid Arthritis Clinical Trials Using a Multi-Biomarker Disease Activity Score as an Inclusion Criterion (2015) Van Vollenhoven R, Bolce R, Hambardzumyan K, Saevarsdottir S, Forslind K, Petersson I, Sasso E, Hwang C, Segurado O, and Geborek P Arthritis & Rheumatol
Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment (2015) Rech J, Hueber AJ, Finzel S, Englbrecht M, Haschka J, Manger B, Kleyer A, Reiser M, Cobra JF, Figueiredo C, Tony HP, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz H-M, Nuesslein H, Alten R, Henes J, Krueger K, Schett G Ann Rheum Dis.
Relationship of multi-biomarker disease activity score and other risk factors with radiographic progression in an observational study of patients with rheumatoid arthritis (2015) Li W, Sasso E, van der Helm-van Mil A and Huizinga T Rheumatology
Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis (2015) Reiss WG, Devenport JN, Low JM, Wu G, Sasso E Rheumatol Int
Outcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritis (2015) Michaud K, Strand V, Shadick NA, Degtiar I, Ford K, Michalopoulos SN and Hornberger J Rheumatology
Back To Top
2014
A multi-biomarker disease activity score tracks clinical response consistently in patients with rheumatoid arthritis treated with different anti-tumor necrosis factor therapies: A retrospective observational study (2014) Hirata S, Li W, Defranoux N, Cavet G, Bolce R, Yamaoka K, Saito K & Tanaka Y Mod Rheumatol.
Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial (2014) Hambardzumyan K, Bolce R, Saevarsdottir S, Cruickshank S, Sasso E, Chernoff D, Forslind K, Petersson IF, Geborek P, van Vollenhoven RF Ann Rheum Dis.
Vectra DA for the objective measurement of disease activity in patients with rheumatoid arthritis. (2014) Segurado OG, Sasso EH. Clin Exp Rheumatol.
Back To Top
2013
Impact of Rheumatoid Arthritis Disease Activity Test on Clinical Practice (2013) Peabody JW, Strand V, Shimkhada R, Lee R, Chernoff D PLoS ONE
Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis (2013) Centola M, Cavet G, Shen Y, Ramanujan S, Knowlton N, Swan KA, Turner M, Sutton C, Smith DR, Haney DJ, Chernoff D, Hesterberg LK, Carulli JP, Taylor PC, Shadick NA, Weinblatt ME, Curtis JR PLoS ONE
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study (2013) Hirata S, Dirven L, Shen Y, Centola M, Cavet G, Lems WF, Tanaka Y, Huizinga WJ and Allaart CF Rheumatology
Back To Top
2012
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis (2012) Burmester GR, Weinblatt ME, McInnes IB, Porter D, Barbarash O, Vatutin M, Szombati I, Esfandiari E, Sleeman MA, Kane CD, Cavet G, Wang B, Godwood A, Magrini F Ann Rheum Dis.
Validation of a Novel Multibiomarker Test to Assess Rheumatoid Arthritis Disease Activity (2012) Curtis Jr, van der Helm-van Mil ah, Knevel R, Huizinga TW, Haney DJ, Shen Y, Ramanujan S, Cavet G, Centola M, Hesterberg LK, Chernoff D, Ford K, Shadick N, Hamburger M, Fleischmann R, Keystone E, and Weinblatt ME Arthritis Care & Res.
Characterization of a multiplex, 12-biomarker test for rheumatoid arthritis (2012) Eastman P.S, Manning WC, Qureshi F, Haney D, Cavet G, Alexander C, Hesterberg LK Pharm Biomed Anal.
Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study (2012) Bakker MF, Cavet G, Jacobs J, Bijlsma J, Haney DJ, Shen Y, Hesterberg LK, Smith D, Centola M, van Roon J, Lafeber F, Welsing P Ann Rheum Dis.
Pre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritis (2012) Zhao X, Qureshi F, Eastman P.S, Manning WC, Alexander C, Robinson WH, Hesterberg LK J Immunol Methods